Sangamo Therapeutics announced that the FDA has cleared the investigational new drug application for its ST-503 program, an investigational epigenetic regul ...
Discover which therapies are expected to grab the major peripheral nerve injuries market share @ Peripheral Nerve Injuries Market Report Peripheral nerve injuries involve damage to the nerves outside ...
Ayotunde Fadayomi has joined the Saint Francis Pain Management Center. He specializes in treating numerous types of pains.
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...
Neuropathic pain refers to pain caused by damage or disease to the nervous system.Neuropathic pain differs in pattern from ...
The resulting paper, “ Clinical study of a micro-implantable pulse generator for the treatment of peripheral neuropathic pain ...
A new study from Monash University in Australia has found that gabapentinoids—commonly used drugs for treating neuropathic ...
The study was conducted at the Federal University of São Paulo and involved 144 diabetic patients, who were treated with ...
Discover the real impact of Arialief for nerve pain relief in our honest Arialief reviews – does it truly work, or is it just ...
The FDA has placed a trial of Rapport Therapeutics’ epilepsy drug for a type of nerve pain on hold while the biotech tweaks ...
The Phase III trial AV001 aims to evaluate QUTENZA® in post- surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after ...